Automation Platform

^AUTOStroke solution

When it comes to optimizing treatment outcomes for stroke patients, speed and accuracy are everything. That’s why you need a solution that can automatically streamline your workflow, consolidate results into a single summary, and alert you to abnormalities for fast triage and tailored treatment decisions. It’s time to discover Canon Medical’s new ^AUTOStroke solution.

An automated workflow reduces the number of time-critical decision points and optimizes resources for treatment.

Optimized patient triage makes it easier for you to prioritize your most challenging and urgent cases with confidence.

Make the most of automated actionable insights delivered to the entire care team, wherever and whenever they need them.

*Chang, P., et. al. “Hybrid 3D/2D Convolutional Neural Network for Hemorrhage Evaluation on Head CT.” AJNR Am J Neuroradiol. 2018 Sep;39(9):1609-1616.

Stroke triage that’s fast and intelligent

Make the right treatment plan for your patients

By harnessing the power of our leading-edge AI technologies, ^AUTOStroke solution helps you swiftly analyze and categorize images, so you can detect the signs of ischemic and hemorrhagic stroke in minutes. Now, with just one solution, you’ll have uncompromised access to information you need to provide the life-saving treatment your patients require – whether that’s a remote specialist review, informed referral decision, or a point-of-care intervention, such as thyrombolysis using tPA or mechanical thrombectomy.

Reduced door-to-puncture time

Automated image analysis algorithms

Optimized decision-making at key triage points

Fast treatment initiation

Canon Medical difference

Uncompromised accuracy every step of the way

The ^AUTOStroke solution integrates a comprehensive set of stroke applications to ensure you get the most accurate representation of what’s going on with your patient.

Non-contrast CT Intracranial Hemorrhage (CINA® ICH) helps you quickly locate multiple variations of intracranial hemorrhage when time is of the essence.

CT Large Vessel Occlusion (CINA® LVO) can help you locate occlusions in cerebral infarction patients.

CT Perfusion maps created using our validated Bayesian CTP+ algorithms, help indicate potential regions of penumbra and infarct core.

Non-contrast CT ASPECTS* (CINA® ASPECTS) delivers scoring of early ischemic stroke signs, which are routinely challenging to detect.

*Not available in all geographies.

Work faster, when time is brain

Insights Results

Easy information sharing across the care team

We’ve made it possible for clinicians to access all the information they require wherever and whenever they need it. Not only does ^AUTOStroke solution enable easy information sharing with your patient’s care team, it also integrates seamlessly with PACS, and can be used with Vitrea’s neurology package to increase your clinical confidence with insights from multiple applications, including Bayesian CTP+ for CT. As a result, clinicians can now be sure that they are always up to date with each patient's personalized clinical data, consolidated and delivered within their regular workflows. Regardless of their location, the stroke team has the validated insights they need to make critical clinical decisions when every second counts.

Partner Testimonials

An endorsement from Dr. Peter Chang, Co-Director of University of California at Irvine (UCI) Center for AI in Diagnostic Medicine

An endorsement from Dr. Kenneth Snyder, MD, PhD, FACS, FAANS; Associate Professor of Neurosurgery at SUNY Buffalo School of Medicine & Biomedical Sciences; Gates Vascular Institute, Jacobs Institute, Buffalo, NY

An endorsement from Dr. Hiroyuki Kawano, Kyorin University, Japan
“After the CT scan, all the rest is automated. This clearly reduces technicians’ workload. (Automation Platform) enables physicians to anticipate how long it may take to complete the process from scanning to image analysis, alleviating wait-time stress for physicians.
I expect a lot from Automation Platform in terms of improved workflow, particularly in the beginning stages of treatment for acute stroke patients who need fast and accurate diagnosis and treatment decisions.”